Biotech startup Sight Diagnostics raises $27.8M in Series C funding
Date: 2019-02-18   Author: Ojaswita Kutepatil  Category: #news

Biotech startup Sight Diagnostics raises $27.8M in Series C funding

Sight Diagnostics, the Israel-based medical devices startup, has reportedly concluded its Series C investment round, with the procurement of $27.8 million in funds. Relevant sources affirmed that the new funding has been led by Israel’s VC firm Longliv Ventures, one of the members of the multinational firm CK Hutchison Group.

Sight Diagnostics, which deploys the AI (Artificial Intelligence) technology for speeding up the blood testing procedure, recently developed a blood testing device called OLO, which calculates the blood count by analyzing cartridges loaded with the patient’s blood. The company revealed in a recent statement that the Series C round had been conducted with the intention of obtaining some strategic investments – particularly from investors that would help advance the firm’s commercial as well as technological expansion. In this context, having Longliv as the lead investor has provided a clear go-to-market pathway for Sight’s OLO blood testing device, given that CK Hutchison group’s portfolio includes over 14,500 health & beauty stores all across Asia and Europe.

For the record, other strategic investors participating in the round included healthcare impact investor Steven Esrick, Jack Nicklaus II, a board member of the Nicklaus Children’s Healthcare Foundation, and an anonymous major medical equipment maker. The existing investors including Go Capital, New Alliance Capital and OurCrowd also participated in the round, with the medtech startup Sight securing over $50 million so far in the funding, disclosing its last year raises of Series A & B.

According to Yossi Pollak, the CEO & Co-founder at Sight, the company successfully sought out individuals and groups who encourage the company in its mission of health improvement using next-generation diagnostics, and more importantly who add valuable financial support. He also revealed that the company is already gaining positive traction throughout Europe and is looking out for more strategic partners to help the company circulate OLO across major global markets.

Reportedly, the funds are likely to be used by Sight in research & development for expanding the set of diagnostic tests offered through OLO.



About Author


Ojaswita Kutepatil

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, worked as a BDE and Technical Engineer before switching her profession to content writing. Currently, she works at AlgosOnline. as an Content writer, where she pens down write-ups pertaining to the market res...

Read More

More from Ojaswita


Post Recommendents

Beer Stabilizers Market (2018 – 2024) Growth Analysis by Manufacturers, Regions, Product Types and Application
Author: Rahul Sankrityayan

On the grounds of changing lifestyles & the rising young affluent population, beer stabilizers market dynamics has been witnessing quite a profitable growth graph in the recent years. The skyrocketing rate of beer consumption across the globe ...


LATAM Frozen Bakery Market (2018-2024) Shares, Strategies and Forecasts, Analysis and Overview
Author: Rahul Sankrityayan

Global Market Insights, Inc. has added a new report on LATAM Frozen Bakery Market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defini...


Window And Door Frame Market Analysis, Trends & Forecast over 2019 – 2024
Author: Rahul Varpe

Automotive and aerospace sectors have been witnessing a paradigm shift in terms of window manufacturing. Owing to the shifting trends toward the adoption of fuel efficient vehicles, automakers and aircraft manufacturers have been looking forward t...